From Structural to Functional Characteristics of the Lumbar Multifidus in Low Back Pain

October 16, 2020 updated by: Sofie Rummens, KU Leuven
To delineate the underlying mechanisms that contribute to chronic low back pain, by extending our knowledge on structural characteristics of the lumbar multifidus muscle using ultrasound muscle imaging, and by examining the association of structural features with functional performance, more precisely proprioceptive control.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Leuven and surroudings

Description

Inclusion criteria for chronic low back pain group:

  • Non-specific low back pain, during 3 or more months, without radicular leg pain
  • Modified Low Back Pain Disability Questionnaire > 20%
  • Indication for MRI of the lumbar spine
  • No contra-indications for MRI
  • Informed consent to participate

Inclusion criteria for healthy control group:

  • No history of low back pain needing medical treatment or resulting in limited activity level
  • Any low back pain in the previous 3 months
  • Informed consent to participate

Exclusion criteria for all subjects:

  • Pregnancy
  • Previous trauma or surgery to spine, abdomen or pelvis
  • Structural deformity (e.g. scoliosis)
  • Neurological/neuromuscular/systemic disease
  • Inability to lie prone for 20 minutes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Low back pain group
Individuals with non-specific chronic low back pain
Healthy control group
Healthy individuals without low back pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lumbar multifidus muscle volume measured by 3DfUS
Time Frame: immediately after inclusion in the study
in patients with chronic low back pain
immediately after inclusion in the study
Lumbar multifidus muscle volume measured by MRI
Time Frame: immediately after inclusion in the study
in patients with chronic low back pain
immediately after inclusion in the study
Cross-sectional area of the lumbar multifidus
Time Frame: immediately after inclusion in the study
measured by classic 2D-ultrasound in patients with chronic low back pain and healthy controls
immediately after inclusion in the study
Thickness of the lumbar multifidus
Time Frame: immediately after inclusion in the study
measured by classic 2D-ultrasound in patients with chronic low back pain and healthy controls
immediately after inclusion in the study
Proprioceptive postural control strategies in patients with low back pain with healthy controls
Time Frame: immediately after inclusion in the study
Mean center-of-pressure displacement in response to soleus muscle and/or multifidus muscle vibration (60 Hz, 0.5 mm) during upright standing on two support surfaces.
immediately after inclusion in the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 27, 2020

Primary Completion (Anticipated)

May 1, 2021

Study Completion (Anticipated)

May 1, 2021

Study Registration Dates

First Submitted

July 26, 2018

First Submitted That Met QC Criteria

July 26, 2018

First Posted (Actual)

August 2, 2018

Study Record Updates

Last Update Posted (Actual)

October 19, 2020

Last Update Submitted That Met QC Criteria

October 16, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • s60404

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe